TNFSF10 and melanoma: Although many types of cancers are sensitive to TRAIL-induced apoptosis, substantial numbers of cancer cells are resistant to TRAIL, especially highly malignant tumors such as pancreatic cancer, melanoma, and neuroblastoma [119].